Phase II trial of panitumumab plus FOLFOX4 or FOLFIRI in subjects with KRAS wild-type colorectal cancer and liver-limited disease: The PLANET study.-Reference-Cited by-同舟云学术

Phase II trial of panitumumab plus FOLFOX4 or FOLFIRI in subjects with KRAS wild-type colorectal cancer and liver-limited disease: The PLANET study.

Published:2014-05-20 Issue:15_suppl Volume:32 Page:3560-3560
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Abad Albert¹,Massuti Bartomeu²,Gravalos Cristina³,Escudero Pilar⁴,Guillen Carmen⁵,Manzano Jose Luis⁶,Gomez M.Auxiliadora⁷,Safont Maria Jose⁸,Gallego Plazas Javier⁹,Sastre Javier¹⁰,Pericay Carles¹¹,Dueñas Rosario¹²,López-López Carlos¹³,Losa Ferran¹⁴,Valladares Ayerbes Manuel¹⁵,González Encarnación¹⁶,Yuste Ana¹⁷,Carrato Alfredo⁵,Aranda Enrique¹⁸

Affiliation:

1. University Hospital Germans Trias i Pujol-ICO, Barcelona, Spain

2. Alicante University Hospital, Alicante, Spain

3. Hospital 12 de Octubre, Madrid, Spain

4. Hospital Clínico, Universitario Lozano Blesa, Zaragoza, Spain

5. Hospital Universitario Ramon y Cajal, Medical Oncology Department, Madrid, Spain

6. Institut Català d'Oncologia, Hospital Universitario German Trias i Pujol, Badalona, Spain

7. Medical Oncology Department, University Reina Sofia Hospital, Biomedical Research Institute Maimonidas, Cordoba, Spain

8. Hospital General de Valencia, Valencia, Spain

9. Department of Medical Oncology, Elche General University Hospital, Alicante, Spain

10. Hospital Universitario Clínico San Carlos, Madrid, Spain

11. Hospital de Sabadell, Corporació Sanitària Parc Taulí, Sabadell, Spain

12. Complejo Hospitalario de Jaén, Jaén, Spain

13. Hospital Universitario Marqués de Valdecilla, Santander, Spain

14. Hospital de Hospitalet, Barcelona, Spain

15. Oncology Service, Complejo Hospitalario Universitario A Coruña, A Coruña, Spain

16. Hospital Virgen de las Nieves, Granada, Spain

17. Hospital General Universitario, Alicante, Spain

18. Reina Sofía University Hospital, Córdoba, Spain

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/jco.2014.32.15_suppl.3560

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Resistance to anti-epidermal growth factor receptor in metastatic colorectal cancer: What does still need to be addressed?;Cancer Treatment Reviews;2020-06

2. Prognostic Model for Resected Squamous Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment;Journal of Thoracic Oncology;2018-04

3. FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer;World Journal of Surgical Oncology;2018-03-27

4. The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection;European Journal of Surgical Oncology;2017-11

5. Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials;Journal of Cancer Research and Clinical Oncology;2017-10-28